Senior insider sale
EVP & Co-Head Research & Inv. at ROYALTY PHARMA PLC — senior position signals high conviction
$2.46M
45.56K shares
What this filing means
URIST MARSHALL plans to sell 45.56K shares of ROYALTY PHARMA PLC valued at approximately $2.46M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/1/2026ACC: 0001964306-26-000306
Officer· EVP & Co-Head Research & Inv.
Since Dec 2020
45.56K
Shares to sell
$2.46M
Approx. market value
9.10K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Equity Performance Award
Granted as part of issuer equity compensation program
5/8/2026
9.10KTotal acquired9.10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/8/2026 | Equity Performance Award Granted as part of issuer equity compensation program | 9.10K | — |
| Total | 9.10K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
9.10K
Market value
$502.1K
6/24/2026
—Completed
Units to sell
13.68K
Market value
$721.8K
5/20/2026
—Completed
Units to sell
13.68K
Market value
$726.1K
5/14/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
9.10K
Market value
$508.5K
7/1/2026
Total
Units
45.56K
Value
$2.46M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/24/2026 | 9.10K | $502.1K | — | Completed |
5/20/2026 | 13.68K | $721.8K | — | Completed |
5/14/2026 | 13.68K | $726.1K | — | Completed |
| Planned — Approximate Date | ||||
7/1/2026 | 9.10K | $508.5K | NASDAQ | Planned |
| Total | 45.56K | $2.46M | ||